Companies across Galveston County cities saw 7 FDA citations in 2025

Sridhar Mantha, Acting Chief Information Officer of FDA
Sridhar Mantha, Acting Chief Information Officer of FDA
0Comments

There was one company in a city associated with Galveston County that received FDA citations as a result of one inspection conducted in the county in 2025, according to the U.S. Food and Drug Administration (FDA).

No companies were cited in the previous year.

The citations in the county include:

  • The responsibilities and procedures applicable to the quality control unit are not in writing.
  • Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
  • Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.

The company cited was involved in the Veterinary sector.

The company cited should take a voluntary action to correct its managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Companies Located within Galveston County Cities and the Citations They Received in 2025
Company NameArea of BusinessInspection DateIssue Cited
Safari Stem Cell, LLCVeterinary01/10/2025Procedures not in writing, fully followed
Safari Stem Cell, LLCVeterinary01/10/2025Environmental Monitoring System
Safari Stem Cell, LLCVeterinary01/10/2025Absence of Written Procedures
Safari Stem Cell, LLCVeterinary01/10/2025Testing and release for distribution
Safari Stem Cell, LLCVeterinary01/10/2025Microbiological testing
Safari Stem Cell, LLCVeterinary01/10/2025Failing to test for penicillin cross-contamination
Safari Stem Cell, LLCVeterinary01/10/2025Dates not included for each significant step
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

Alvin Medicaid spending for Temporary National Codes (Non-Medicare) tops $4 million in 2024

Medicaid payments associated with the Temporary National Codes (Non-Medicare) category in Alvin rose 4.6% to $4,011,836 in 2024, signaling shifts in service utilization and reimbursement.

Dr. Mehmet Oz CMS Administrator

Webster Medicaid billing for Procedures / Professional Services climbs to $256,596 in 2024

Webster’s Medicaid providers reported $256,596 in claims for the Procedures / Professional Services category in 2024, marking a 212.4% increase over the prior year.

Kyle Diamantas, J.D., Deputy Commissioner for Human Foods of FDA

FDA inspects Cyto Power, Inc. facility in Pearland on April 22

FDA records show an inspection at Cyto Power, Inc. in Pearland on April 22 focused on food standards, labeling, economic concerns, and biological food hazards.